account_id none on file
legal_name AIM ImmunoTech Inc.
ticker AIM
cik 946644
domain aimimmuno.com
linkedin_company_url https://www.linkedin.com/company/aimimmuno/?viewAsMember=true
entry_point_account_id none on file
exchange NYSE
sector Health Care
hq Ocala, FL, United States
sector index/company/sector/health-care/
calls 0 filings 2 executives 2 family 0
why_nownone on file
callsnone on file
filings
our CEO and CFO concluded that the disclosure controls and procedures were effective as of June 30, 2026, to ensure that material information
filing / Aug 7, 2026 / receipt
which is commonly referred to as “ householding ,” potentially means extra convenience for stockholders and cost savings
filing / Jun 25, 2026 / receipt
executives
| Peter W. Rodino | Chief Operating Officer | - | receipt |
| Thomas K. Equels | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-16 | earnings call | scheduled | ir |
changes
| 2019-10-17 | Chief Operating Officer, appointed | sec_8k |
| 2016-02-26 | Chief Executive Officer, appointed | sec_8k |
| 2013-11-18 | Chief Financial Officer, departed | sec_8k |
mcp_package_hint
slug aim-immunotech-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$